Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
LSM7: a novel genetic variant in ultra-rare cases of leukodystrophy
EF 2018-19
Résumé
Leukodystrophies (LD) are a diverse group of genetically-determined neurodegenerative disorders that affect the central nervous system. We recently uncovered a novel gene, LSM7 which has been implicated in ultra-rare cases of non-hypomyelinating leukodystrophy (non-HLD). We propose in depth functional studies to determine the role and pathophysiological mechanisms of LSM7 in disease. LSM7 functions in two complexes: Lsm1-7 and Lsm2-8. Our goal is to investigate how our two variants alter the gene’s functional role in the cells. As such, the next steps in this project include proteomic studies looking at the stability of the human mutated LSM7 RNA, its localization in the cell, as well as its ability to interact with its binding partners to form complexes and carry out its functions. These experiments will be conducted with the help of our collaborators, using techniques such as affinity purification, mass spectroscopy and fluorescent labelling. Additionally, we will perform studies in yeast analyzing the effects of the LSM7 variants on the formation of the two complexes, as well as complex interactions with other proteins/RNAs such as Pat1 and U6 snRNA. Specifically, we will focus on mRNA degradation, the principal function of Lsm1-7 complex as well as splicing, the primary function of the Lsm2-8 complex. We predict that the LSM7 variants do indeed influence LSM complex formation and/or activity and hence lead to disrupted mRNA decay and spliceosomal function. We are confident that the results of this study will set the ground for directed research on therapeutic strategies to rescue these important cellular processes and give hope to the present and future patients affected by LSM7-related leukodystrophy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406311
Name
Derksen Alexa R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
LSM7: a novel genetic variant in ultra-rare cases of leukodystrophy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Degenerative Neurogenetic Diseases; Genetics; Leukodystrophy; Lsm Proteins; Lsm1-7; Lsm2-8; Lsm7; Mrna Decay; Pediatric Leukodystrophies; Splicing
Abstract
Leukodystrophies (LD) are a diverse group of genetically-determined neurodegenerative disorders that affect the central nervous system. We recently uncovered a novel gene, LSM7 which has been implicated in ultra-rare cases of non-hypomyelinating leukodystrophy (non-HLD). We propose in depth functional studies to determine the role and pathophysiological mechanisms of LSM7 in disease. LSM7 functions in two complexes: Lsm1-7 and Lsm2-8. Our goal is to investigate how our two variants alter the gene’s functional role in the cells. As such, the next steps in this project include proteomic studies looking at the stability of the human mutated LSM7 RNA, its localization in the cell, as well as its ability to interact with its binding partners to form complexes and carry out its functions. These experiments will be conducted with the help of our collaborators, using techniques such as affinity purification, mass spectroscopy and fluorescent labelling. Additionally, we will perform studies in yeast analyzing the effects of the LSM7 variants on the formation of the two complexes, as well as complex interactions with other proteins/RNAs such as Pat1 and U6 snRNA. Specifically, we will focus on mRNA degradation, the principal function of Lsm1-7 complex as well as splicing, the primary function of the Lsm2-8 complex. We predict that the LSM7 variants do indeed influence LSM complex formation and/or activity and hence lead to disrupted mRNA decay and spliceosomal function. We are confident that the results of this study will set the ground for directed research on therapeutic strategies to rescue these important cellular processes and give hope to the present and future patients affected by LSM7-related leukodystrophy.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Derksen, Alexa R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~